Fair Value Measurements (Tables)
|
3 Months Ended |
Mar. 31, 2025 |
Fair Value Disclosures [Abstract] |
|
Schedule of Categorized Investments Recorded at Fair Value among Levels |
We have categorized our assets and liabilities that are recorded at fair value on a recurring and nonrecurring basis among levels based on the observability of inputs, or at fair value using NAV per share (or its equivalent) as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2025 | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Measured Using NAV as Practical Expedient | | Total Fair Value | | (in millions of U.S. dollars) | Investments: | | | | | | | | | | Short-term and fixed maturity investments: | | | | | | | | | | U.S. government and agency | $ | — | | | $ | 579 | | | $ | — | | | $ | — | | | $ | 579 | | U.K. government | — | | | 53 | | | — | | | — | | | 53 | | Other government | — | | | 364 | | | — | | | — | | | 364 | | Corporate | — | | | 3,414 | | | 13 | | | — | | | 3,427 | | Municipal | — | | | 105 | | | — | | | — | | | 105 | | Residential mortgage-backed | — | | | 444 | | | — | | | — | | | 444 | | Commercial mortgage-backed | — | | | 742 | | | — | | | — | | | 742 | | Asset-backed | — | | | 759 | | | 30 | | | — | | | 789 | | | | | | | | | | | | | | | | | | | | | | | $ | — | | | $ | 6,460 | | | $ | 43 | | | $ | — | | | $ | 6,503 | | | | | | | | | | | | Funds held (1) | $ | 70 | | | $ | 2,209 | | | $ | 4 | | | $ | 74 | | | $ | 2,357 | | Equities: | | | | | | | | | | Privately held equity investments | $ | — | | | $ | — | | | $ | 384 | | | $ | 71 | | | $ | 455 | | Publicly traded equity investments | 143 | | | 9 | | | 1 | | | — | | | 153 | | Exchange-traded funds | 135 | | | — | | | — | | | — | | | 135 | | Warrant and others | — | | | — | | | 16 | | | — | | | 16 | | | $ | 278 | | | $ | 9 | | | $ | 401 | | | $ | 71 | | | $ | 759 | | Other investments: | | | | | | | | | | | | | | | | | | | | Private equity funds | $ | — | | | $ | — | | | $ | — | | | $ | 1,949 | | | $ | 1,949 | | Private credit funds | — | | | 386 | | | — | | | 529 | | | 915 | | Hedge funds | — | | | — | | | — | | | 386 | | | 386 | | Fixed income funds | — | | | 5 | | | — | | | 370 | | | 375 | | Real estate fund | — | | | — | | | — | | | 427 | | | 427 | | CLO equity funds | — | | | — | | | — | | | 124 | | | 124 | | CLO equities | — | | | 25 | | | — | | | — | | | 25 | | Equity funds | — | | | 5 | | | — | | | — | | | 5 | | | | | | | | | | | | | $ | — | | | $ | 421 | | | $ | — | | | $ | 3,785 | | | $ | 4,206 | | Total Investments, excluding funds held by reinsured companies and equity method investments | $ | 348 | | | $ | 9,099 | | | $ | 448 | | | $ | 3,930 | | | $ | 13,825 | | | | | | | | | | | | | | | | | | | | | | Reinsurance balances recoverable on paid and unpaid losses: | $ | — | | | $ | — | | | $ | 194 | | | $ | — | | | $ | 194 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Other Assets: | | | | | | | | | | Derivatives qualifying as hedging | $ | — | | | $ | 1 | | | $ | — | | | $ | — | | | $ | 1 | | Derivatives not qualifying as hedging | — | | | 11 | | | — | | | — | | | 11 | | Derivative instruments | $ | — | | | $ | 12 | | | $ | — | | | $ | — | | | $ | 12 | | | | | | | | | | | | Losses and LAE: | $ | — | | | $ | — | | | $ | 996 | | | $ | — | | | $ | 996 | | | | | | | | | | | | Other Liabilities: | | | | | | | | | | Derivatives qualifying as hedging | $ | — | | | $ | 5 | | | $ | — | | | $ | — | | | $ | 5 | | Derivatives not qualifying as hedging | — | | | 3 | | | — | | | — | | | 3 | | Derivative instruments | $ | — | | | $ | 8 | | | $ | — | | | $ | — | | | $ | 8 | |
(1) The difference in the amount of funds held shown at fair value and the funds held shown in our unaudited condensed consolidated balance sheet relates to the $2.3 billion of funds held by reinsured companies carried at amortized cost as of March 31, 2025. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2024 | | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Measured Using NAV as Practical Expedient | | Total Fair Value | | | (in millions of U.S. dollars) | Investments: | | | | | | | | | | | Short-term and fixed maturity investments: | | | | | | | | | | | U.S. government and agency | | $ | — | | | $ | 420 | | | $ | — | | | $ | — | | | $ | 420 | | U.K government | | — | | | 44 | | | — | | | — | | | 44 | | Other government | | — | | | 359 | | | — | | | — | | | 359 | | Corporate | | — | | | 3,244 | | | 17 | | | — | | | 3,261 | | Municipal | | — | | | 109 | | | — | | | — | | | 109 | | Residential mortgage-backed | | — | | | 421 | | | — | | | — | | | 421 | | Commercial mortgage-backed | | — | | | 784 | | | — | | | — | | | 784 | | Asset-backed | | — | | | 742 | | | 30 | | | — | | | 772 | | | | | | | | | | | | | | | | | | | | | | | | | | — | | | 6,123 | | | 47 | | | — | | | 6,170 | | | | | | | | | | | | | Funds held (1) | | $ | 70 | | | $ | 2,305 | | | $ | 5 | | | $ | 71 | | | $ | 2,451 | | Equities: | | | | | | | | | | | Privately held equity investments | | $ | — | | | $ | — | | | $ | 389 | | | $ | 71 | | | $ | 460 | | Publicly traded equity investments | | 166 | | | 9 | | | 1 | | | — | | | 176 | | Exchange-traded funds | | 151 | | | — | | | — | | | — | | | 151 | | Warrant and others | | — | | | — | | | 16 | | | — | | | 16 | | | | $ | 317 | | | $ | 9 | | | $ | 406 | | | $ | 71 | | | $ | 803 | | Other investments: | | | | | | | | | | | Private equity funds | | $ | — | | | $ | — | | | $ | — | | | $ | 1,926 | | | $ | 1,926 | | Private credit funds | | — | | | 363 | | | — | | | 501 | | | 864 | | Hedge funds | | — | | | — | | | — | | | 410 | | | 410 | | Real estate funds | | — | | | — | | | — | | | 401 | | | 401 | | Fixed income funds | | — | | | 5 | | | — | | | 364 | | | 369 | | CLO equity funds | | — | | | — | | | — | | | 162 | | | 162 | | CLO equities | | — | | | 52 | | | — | | | — | | | 52 | | Equity funds | | — | | | 4 | | | — | | | — | | | 4 | | | | | | | | | | | | | | | $ | — | | | $ | 424 | | | $ | — | | | $ | 3,764 | | | $ | 4,188 | | Total Investments, excluding funds held by reinsured companies and equity method investments | | $ | 387 | | | $ | 8,861 | | | $ | 458 | | | $ | 3,906 | | | $ | 13,612 | | | | | | | | | | | | | | | | | | | | | | | | Reinsurance balances recoverable on paid and unpaid losses: | | $ | — | | | $ | — | | | $ | 179 | | | $ | — | | | $ | 179 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Other Assets: | | | | | | | | | | | Derivatives qualifying as hedging | | $ | — | | | $ | 2 | | | $ | — | | | $ | — | | | $ | 2 | | Derivatives not qualifying as hedging | | — | | | 3 | | | — | | | — | | | 3 | | Derivative instruments | | $ | — | | | $ | 5 | | | $ | — | | | $ | — | | | $ | 5 | | | | | | | | | | | | | Losses and LAE: | | $ | — | | | $ | — | | | $ | 997 | | | $ | — | | | $ | 997 | | | | | | | | | | | | | Other Liabilities: | | | | | | | | | | | | | | | | | | | | | | Derivatives not qualifying as hedging | | $ | — | | | $ | 7 | | | $ | — | | | $ | — | | | $ | 7 | | | | | | | | | | | | |
(1) The difference in the amount of funds held shown at fair value and the funds held shown in our consolidated balance sheet relates to the $2.5 billion of funds held by reinsured companies carried at amortized cost as of December 31, 2024.
|
Schedule of Reconciliation for Assets Measured at Fair Value on a Recurring Basis |
The following table presents a reconciliation of the beginning and ending balances for all investments measured at fair value on a recurring basis using Level 3 inputs: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | | March 31, 2025 | | | | | Fixed maturity investments | | Equities | | Total | | | | | Corporate | | | | | | Asset-backed | | Privately-held Equities | | Public Equities | | Warrants and Other | | | | | (in millions of U.S. dollars) | Beginning fair value | | $ | 17 | | | | | | | $ | 30 | | | $ | 389 | | | $ | 1 | | | $ | 16 | | | $ | 453 | | | | | | | | | | | | | | | | | | | | | | | Sales and paydowns | | (5) | | | | | | | — | | | — | | | — | | | — | | | (5) | | | | Total fair value changes in trading securities, funds held and other investments (1) | | 1 | | | | | | | — | | | (5) | | | — | | | — | | | (4) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Ending fair value | | $ | 13 | | | | | | | $ | 30 | | | $ | 384 | | | $ | 1 | | | $ | 16 | | | $ | 444 | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | | March 31, 2024 | | | | Fixed maturity investments | | Equities | | Total | | | | Corporate | | | | | | Asset-backed | | Privately-held Equities | | Public Equities | | | | | | | (in millions of U.S. dollars) | Beginning fair value | | $ | 12 | | | | | | | $ | 11 | | | $ | 299 | | | $ | 1 | | | | | $ | 323 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total fair value changes in trading securities, funds held and other investments (1) | | — | | | | | | | — | | | (2) | | | — | | | | | (2) | | | Transfer into Level 3 from Level 2 | | 5 | | | | | | | 15 | | | — | | | — | | | | | 20 | | | | | | | | | | | | | | | | | | | | | Ending fair value | | $ | 17 | | | | | | | $ | 26 | | | $ | 297 | | | $ | 1 | | | | | $ | 341 | | |
(1) Fair value changes in trading securities, funds held and other investments included in our consolidated statements of operations is equal to the change in fair value changes in trading securities, funds held and other investments relating to assets held at the end of the reporting period. The following table presents a reconciliation of the beginning and ending balances for the embedded derivative measured at fair value on a recurring basis using Level 3 inputs: | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | | 2025 | | 2024 | | | | | | (in millions of U.S. dollars) | Beginning fair value | $ | 5 | | | $ | 40 | | | | | | | | | | | | | | Total fair value changes | (1) | | | (18) | | | | | | | | | | | | | | Ending fair value | $ | 4 | | | $ | 22 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | 2025 | | 2024 | | Liability for losses and LAE | | Reinsurance balances recoverable | | Net | | Liability for losses and LAE | | Reinsurance balances recoverable | | Net | | (in millions of U.S. dollars) | Beginning fair value | $ | 997 | | | $ | 183 | | | $ | 814 | | | $ | 1,163 | | | $ | 217 | | | $ | 946 | | | | | | | | | | | | | | Incurred losses and LAE: | | | | | | | | | | | | (Reduction) increase in estimates of ultimate losses | (2) | | | 1 | | | (3) | | | (6) | | | (9) | | | 3 | | Reduction in unallocated LAE | (1) | | | — | | | (1) | | | (2) | | | — | | | (2) | | Change in fair value due to changes in : | | | | | | | | | | | | Average payout | 9 | | | 1 | | | 8 | | | 10 | | | 2 | | | 8 | | Corporate bond yield | (3) | | | — | | | (3) | | | (16) | | | (3) | | | (13) | | Risk cost of capital | — | | | — | | | — | | | 1 | | | — | | | 1 | | | | | | | | | | | | | | | | | | | | | | | | | | Total change in fair value | 6 | | | 1 | | | 5 | | | (5) | | | (1) | | | (4) | | Total incurred losses and LAE | 3 | | | 2 | | | 1 | | | (13) | | | (10) | | | (3) | | Paid losses | (26) | | | 6 | | | (32) | | | (39) | | | (6) | | | (33) | | | | | | | | | | | | | | Effect of exchange rate movements | 22 | | | 3 | | | 19 | | | (13) | | | 6 | | | (19) | | Ending fair value | $ | 996 | | | $ | 194 | | | $ | 802 | | | $ | 1,098 | | | $ | 207 | | | $ | 891 | |
|
Schedule of Valuation Inputs and Techniques |
The table below presents the quantitative information related to the fair value measurements for our fixed maturity and equity investments measured at fair value on a recurring and non-recurring basis using Level 3 inputs:
| | | | | | | | | | | | | | | | | | | | | | | Qualitative Information about Level 3 Fair Value Measurements | Valuation Techniques | | Fair Value as of March 31, 2025 | | | | Unobservable Input | | Range (Average) (1) | | | (in millions of U.S. dollars) | | | | | | | Recurring basis: | | | | | | | | | | | | | | | | | | Fixed maturities | | | | | | | | | Corporate | | | | | | | | | Discounted cash flow | | $ | 13 | | | | | YTM; implied total yield | | 6.04% - 9.65% | Asset-backed | | | | | | | | | Discounted cash flow | | 30 | | | | YTM | | 6.32% - 9.41% | Total fixed maturities | | $ | 43 | | | | | | | | | | | | | | | | | Equity investments | | | | | | | | | Privately held equity investments | | | | | | | | | | | | | | | | | | Guideline company methodology; Option pricing model | | $ | 220 | | | | | P/BV multiple P/BV (excluding AOCI) multiple Expected term | | 1.3x - 1.8x 1.3x -1.7x 1-3 years | Guideline companies method | | 67 | | | | | P/BV multiple Price/2025 earnings | | 1.6x - 1.7x 8x - 9.5x | Guideline companies method | | 36 | | | | | LTM Enterprise Value/ EBITDA multiples | | 14.5x - 15.9x | Earnings | | 4 | | | | | Multiple on earnings | | 5x | Dividend discount model | | 56 | | | | | Discount rate | | 7.4% | | | 383 | | | | | | | | | | | | | | | | | Publicly traded equity investments | | | | | | | | | Discounted cash flow | | 1 | | | | | Implied total yield | | 8.50% | | | | | | | | | | Warrants and Other | | | | | | | | | Black-Scholes model | | 16 | | | | | Expected term in years | | 9.5 years | Total recurring equity Investments | | $ | 400 | | | | | | | | | | | | | | | | | Non-recurring basis: | | | | | | | | | | | | | | | | | | Privately held equity investments | | | | | | | | | Cost as approximation of fair value | | $ | 1 | | | | | Cost as approximation of fair value | | | | | | | | | | | | Total Recurring and Non-recurring equity investments | | $ | 401 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1) The average represents the arithmetic average of the inputs and is not weighted by the relative fair value. The table below presents the qualitative information related to the fair value measurements for the embedded derivative on our funds held by reinsured companies measured at fair value on a recurring basis using Level 3 inputs: | | | | | | | | | | | | | | | | | | | | | Qualitative Information about Level 3 Fair Value Measurements | Valuation Techniques | | Fair Value as of March 31, 2025 | | Unobservable Input | | Average | | | (in millions of U.S. dollars) | | | | | Monte Carlo simulation model; Discounted cash flow analysis | | $ | 4 | | | Volatility rate; Expected Loss Payments | | 3.46% $210 million | | | | | | | | | | | | | | |
|
Schedule of Reconciliation for Liabilities Measured at Fair Value on a Recurring Basis |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | 2025 | | 2024 | | Liability for losses and LAE | | Reinsurance balances recoverable | | Net | | Liability for losses and LAE | | Reinsurance balances recoverable | | Net | | (in millions of U.S. dollars) | Beginning fair value | $ | 997 | | | $ | 183 | | | $ | 814 | | | $ | 1,163 | | | $ | 217 | | | $ | 946 | | | | | | | | | | | | | | Incurred losses and LAE: | | | | | | | | | | | | (Reduction) increase in estimates of ultimate losses | (2) | | | 1 | | | (3) | | | (6) | | | (9) | | | 3 | | Reduction in unallocated LAE | (1) | | | — | | | (1) | | | (2) | | | — | | | (2) | | Change in fair value due to changes in : | | | | | | | | | | | | Average payout | 9 | | | 1 | | | 8 | | | 10 | | | 2 | | | 8 | | Corporate bond yield | (3) | | | — | | | (3) | | | (16) | | | (3) | | | (13) | | Risk cost of capital | — | | | — | | | — | | | 1 | | | — | | | 1 | | | | | | | | | | | | | | | | | | | | | | | | | | Total change in fair value | 6 | | | 1 | | | 5 | | | (5) | | | (1) | | | (4) | | Total incurred losses and LAE | 3 | | | 2 | | | 1 | | | (13) | | | (10) | | | (3) | | Paid losses | (26) | | | 6 | | | (32) | | | (39) | | | (6) | | | (33) | | | | | | | | | | | | | | Effect of exchange rate movements | 22 | | | 3 | | | 19 | | | (13) | | | 6 | | | (19) | | Ending fair value | $ | 996 | | | $ | 194 | | | $ | 802 | | | $ | 1,098 | | | $ | 207 | | | $ | 891 | |
|
Schedule of Quantitative Information |
Below is a summary of the quantitative information regarding the significant observable and unobservable inputs used in the internal model to determine fair value on a recurring basis: | | | | | | | | | | | | | | | Valuation Technique | | March 31, 2025 | | December 31, 2024 | Unobservable (U) and Observable (O) Inputs | Weighted Average | Internal model | Corporate bond yield (O) | A Rated | | A Rated | Internal model | Credit spread for Instrument-specific credit risk (U) | 0.40% | | 0.40% | Internal model | Risk cost of capital (U) | 6.15% | | 6.15% | Internal model | Weighted average cost of capital (U) | 9.25% | | 9.25% | Internal model | Average payout - liability (U) | 8.01 years | | 8.10 years | Internal model | Average payout - reinsurance balances recoverable on paid and unpaid losses (U) | 8.04 years | | 8.39 years |
|
Schedule of Senior and Subordinated Notes |
The following table presents the fair values of our Senior and Junior Subordinated Notes carried at amortized cost: | | | | | | | | | | | | | | | | | March 31, 2025 | | | Amortized Cost | | Fair Value | | | (in millions of U.S. dollars) | 4.95% Senior Notes due 2029 | | $ | 497 | | | $ | 498 | | 3.10% Senior Notes due 2031 | | 496 | | | 432 | | Total Senior Notes | | $ | 993 | | | $ | 930 | | 5.75% Junior Subordinated Notes due 2040 | | $ | 116 | | | $ | 117 | | 5.50% Junior Subordinated Notes due 2042 | | 494 | | | 487 | | 7.50% Junior Subordinated Notes due 2045 | | 345 | | | 355 | | | | | | | Total Junior Subordinated Notes | | $ | 955 | | | $ | 959 | | Total debt | | $ | 1,948 | | | $ | 1,889 | |
Our debt obligations were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2025 | | December 31, 2024 | Facility | | Origination | | Term | | Principal | | (Unamortized Cost) / Fair Value Adjustments | | Carrying Value | | (Unamortized Cost) / Fair Value Adjustments | | Carrying Value | | | | | | | (in millions of U.S. dollars) | | | | | | | | | | | | | | | | 4.95% Senior Notes due 2029 | | May 2019 | | 10 years | | $ | 500 | | | $ | (3) | | | $ | 497 | | | $ | (3) | | | $ | 497 | | 3.10% Senior Notes due 2031 | | August 2021 | | 10 years | | 500 | | | (4) | | | 496 | | | (4) | | | 496 | | Total Senior Notes | | | | | | | | | | 993 | | | | | 993 | | 5.75% Junior Subordinated Notes due 2040 (1) | | August 2020 | | 20 years | | 117 | | | (1) | | | 116 | | | (4) | | | 346 | | 5.50% Junior Subordinated Notes due 2042 | | January 2022 | | 20 years | | 500 | | | (6) | | | 494 | | | (6) | | | 494 | | 7.50% Junior Subordinated Notes due 2045 | | March 2025 | | 20 years | | 350 | | | (5) | | | 345 | | | — | | | — | | Total Junior Subordinated Notes | | | | | | | | | | 955 | | | | | 840 | | EGL Revolving Credit Facility (2) | | May 2023 | | 5 years | | | | | | — | | | | | — | | Total debt obligations | | | | | | | | $ | 1,948 | | | | | $ | 1,833 | |
(1) As of December 31, 2024 the principal amount of these notes were $350 million. (2) Origination date on EGL Revolving Credit Facility represents the date of the most recent amendment and restatement.
|